Mesalamine 800 mg / 1 Tablet 180 Tablet, Delayed Release
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 68382-0435-28 |
|---|---|
| Product NDC | 68382-0435 |
| Generic Drug Name | mesalamine |
| Brand Name | mesalamine |
| Manufacturer | Zydus Pharmaceuticals USA Inc. |
| Strength | 800 mg / 1 |
| Dosage Form | Tablet |
| Drug Type | Oral |
| Package Quantity | 180 Tablet, Delayed Release |
| Package Description | 180 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-435-28) |
| Active Ingredients | Mesalamine |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
mesalamine 800 mg / 1 Tablet is tracked under NDC 68382-0435-28 and rolls up into product family 68382-0435. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 180 Tablet, Delayed Release.
- Manufacturer: Zydus Pharmaceuticals USA Inc..
- Dosage form: Tablet.
- Family size: 2 indexed presentations.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Potential alternatives with matching presentation
Open the comparison hub or review package-level listings from 5 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.
Mesalamine 800 mg / 1 Tablet 180 Tablet, Delayed Release, NDC 68382-0435-28, is a Zydus Pharmaceuticals USA Inc. 800 mg / 1 tablet presentation packaged as 180 Tablet, Delayed Release. Historical public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 68382-0435-28
- Digits-only NDC 11: 68382043528
- Possible 10-digit display format: 68382-435-28 (6838243528)
Helpful product links
- Search by brand name: mesalamine
- NDC 11: 68382-0435-28
- Product family NDC: 68382-0435
- Other package sizes in this family: 10 Blister Pack
- Compare related presentations: Mesalamine 800 mg / 1 Tablet 10 Blister Pack
- VA classification code: GA900
- VA classification code description: GASTRIC MEDICATIONS,OTHER
- CMOP ID: M0899
- VUID: 4029371